OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Familial Amyotrophic Lateral Sclerosis
Khrista Boylan
Neurologic Clinics (2015) Vol. 33, Iss. 4, pp. 807-830
Open Access | Times Cited: 166

Showing 1-25 of 166 citing articles:

ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?
Rita Mejzini, Loren L. Flynn, Ianthe Pitout, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 658

Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants
Shahram Saberi, Jennifer E. Stauffer, Derek Schulte, et al.
Neurologic Clinics (2015) Vol. 33, Iss. 4, pp. 855-876
Open Access | Times Cited: 247

MAP/ERK Signaling in Developing Cognitive and Emotional Function and Its Effect on Pathological and Neurodegenerative Processes
Héctor Albert‐Gascó, Francisco Ros‐Bernal, Esther Castillo‐Gomez, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4471-4471
Open Access | Times Cited: 153

Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders
Jessica R. Cohen, Annette Mathew, Kirk D. Dourvetakis, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 511-511
Open Access | Times Cited: 34

Copper Delivery by Metallochaperone Proteins
Amy C. Rosenzweig
Accounts of Chemical Research (2000) Vol. 34, Iss. 2, pp. 119-128
Closed Access | Times Cited: 269

Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis
Nadine Bakkar, Tina Kovalik, Ileana Lorenzini, et al.
Acta Neuropathologica (2017) Vol. 135, Iss. 2, pp. 227-247
Open Access | Times Cited: 171

Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention
Teresa Cunha‐Oliveira, Liliana Montezinho, Catarina Mendes, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-29
Open Access | Times Cited: 137

Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients
D. Saucier, Gabriel Wajnberg, Jeremy Roy, et al.
Brain Research (2018) Vol. 1708, pp. 100-108
Closed Access | Times Cited: 107

Neuro-Coagulopathy: Blood Coagulation Factors in Central Nervous System Diseases
Ciro De Luca, Assunta Virtuoso, Nicola Maggio, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 10, pp. 2128-2128
Open Access | Times Cited: 91

Amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease (AD) are characterised by differential activation of ER stress pathways: focus on UPR target genes
Luigi Montibeller, Jacqueline de Belleroche
Cell Stress and Chaperones (2018) Vol. 23, Iss. 5, pp. 897-912
Open Access | Times Cited: 87

CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
Tesfaye Wolde Tefera, Frederik J. Steyn, Shyuan T. Ngo, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 86

Contribution of astrocytes to neuropathology of neurodegenerative diseases
Çiğdem Acıoğlu, Lun Li, Stella Elkabes
Brain Research (2021) Vol. 1758, pp. 147291-147291
Closed Access | Times Cited: 80

Nearly 30 Years of Animal Models to Study Amyotrophic Lateral Sclerosis: A Historical Overview and Future Perspectives
Tiziana Bonifacino, Roberta Arianna Zerbo, Matilde Balbi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12236-12236
Open Access | Times Cited: 64

Oligodendrocyte Dysfunction in Amyotrophic Lateral Sclerosis: Mechanisms and Therapeutic Perspectives
Stefano Raffaele, Marta Boccazzi, Marta Fumagalli
Cells (2021) Vol. 10, Iss. 3, pp. 565-565
Open Access | Times Cited: 63

CRISPR/Cas9 genome editing for neurodegenerative diseases.
Jafar Nouri Nojadeh, Nur Seren Bildiren Eryilmaz, Berrin İmge Ergüder
PubMed (2023) Vol. 22, pp. 567-582
Closed Access | Times Cited: 28

Mitochondria: A Promising Convergent Target for the Treatment of Amyotrophic Lateral Sclerosis
Teresa Cunha‐Oliveira, Liliana Montezinho, Rui F. Simões, et al.
Cells (2024) Vol. 13, Iss. 3, pp. 248-248
Open Access | Times Cited: 11

Intrathecal administration of a novel siRNA modality extends survival and improves motor function in the SOD1G93A ALS mouse model
Chunling Duan, Moorim Kang, Xiaojie Pan, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 1, pp. 102147-102147
Open Access | Times Cited: 11

Schwann Cells in Neuromuscular Disorders: A Spotlight on Amyotrophic Lateral Sclerosis
Kathryn R. Moss, Smita Saxena
Cells (2025) Vol. 14, Iss. 1, pp. 47-47
Open Access | Times Cited: 1

Muscle Matters: Transforming Amyotrophic Lateral Sclerosis Diagnostics with Next-Gen Biosensors and Smart Detection
Saumitra Singh, Sameer Khan, Shahbaz Khan, et al.
ACS Chemical Neuroscience (2025)
Closed Access | Times Cited: 1

Genetic epidemiology of amyotrophic lateral sclerosis
Daniëlle Majoor‐Krakauer, PJ Willems, Albert Hofman
Clinical Genetics (2003) Vol. 63, Iss. 2, pp. 83-101
Open Access | Times Cited: 147

Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms
Claudia Figueroa‐Romero, Junguk Hur, J. Simon Lunn, et al.
Molecular and Cellular Neuroscience (2015) Vol. 71, pp. 34-45
Open Access | Times Cited: 87

Beyond muscles: The untapped potential of creatine
Lisa A. Riesberg, Stephanie A. Weed, Thomas L. McDonald, et al.
International Immunopharmacology (2016) Vol. 37, pp. 31-42
Open Access | Times Cited: 83

Genotype-phenotype correlations of amyotrophic lateral sclerosis
Hong‐Fu Li, Zhi‐Ying Wu
Translational Neurodegeneration (2016) Vol. 5, Iss. 1
Open Access | Times Cited: 81

The genotype–phenotype landscape of familial amyotrophic lateral sclerosis in Australia
Emily P. McCann, Kelly L. Williams, Jennifer A. Fifita, et al.
Clinical Genetics (2017) Vol. 92, Iss. 3, pp. 259-266
Closed Access | Times Cited: 69

Page 1 - Next Page

Scroll to top